Search
Searching with a thematic focus on Trade Policy, WTO, WTO Doha
Showing 131-140 of 143 results
Pages
- Document
Agricultural policies in OECD countries: monitoring and evaluation 2002
Organisation for Economic Co-operation and Development, 2002Agricultural trade policy is at the centre of debate. The WTO is now re-negotiating the Agreement of Agriculture (AoA), while the European Union is working at the reform of the Common Agriculture Policy (CAP) which should be implemented by 2006.DocumentThe Doha agenda and intellectual property rights
Asian Development Bank Institute, 2002This paper reviews the possible outcomes of declarations made at the WTO Ministerial in Doha concerning the TRIPS agreement.DocumentCan 'the spirit of Doha' be kept alive?
SciDev.Net, 2003Background and commentary from SciDev.Net on the circumstances leading up to the failure of the TRIPS Council to reach agreement on access to generic drugs for developing countries by the deadline set in the "Doha Declaration".Dickson places the blame for this failure firmly in the hands of the pharmaceutical industry who sought sharp restrictions based on the scope of diseases covered and theDocumentThe FTAA, access to HIV/AIDS treatment, and human rights
Human Rights Watch, 2002This briefing paper begins by giving an outline of the WTO’s Trade Related Aspects of Intellectual Property Agreement (TRIPS) and of the Doha declaration by WTO members, which states that countries can bypass patents in medical emergencies.The paper argues that countries in the Free Trade Area of the Americas (FTAA) should resist pressure from the Office of the United States Trade RepresentativDocumentDoha, is it really a development round?
Carnegie Endowment for International Peace, 2002This paper questions the validity of the Doha round as a serious aid to international development issues - specifically provisions to less developed countries.The geoploitical realities of 9/11 meant that developing countries were not in such a strong position to pursue a positive pro active agenda for trade and development .DocumentAmended patents act and access to medicines after Doha
International Environmental Law Research Centre, 2002This article examines the ammended India Patents Act which passed into law shortly after the Doha declaration on TRIPS and access to medicines.DocumentIssues linked to Convention on Biological Diversity in the WTO negotiations implementing Doha mandates.
Center for International Environmental Law, 2002This document analyses the content of TRIPS and CBD related mandates contained in the Ministerial texts approved at Doha. It aims at providing developing countries with suggestions for common action in the relevant WTO bodies.DocumentAnthrax, Drug Transnationals, and TRIPs
Foreign Policy in Focus, 2002Opinion piece from the Director of the Public Interest Research Centre in India which looks at TRIPS and the Doha declaration and draws inferences from the recent anthrax crisis in the US.Among the points the author makes are that:By sacrificing the public health concern of its own citizens to protect the private interests of drug TNCs, the U.S.DocumentFrom Uruguay to Doha: agricultural trade negotiations at the World Trade Organization
WTO Watch Trade Observatory, IATP, 2002This discussion paper examines current agricultural trade negotiations at the World Trade Organization, with particular attention to the relationship between liberalization and developing countries’ economic growth and food security.Agriculture remains one of the most highly protected arenas of international trade and that the cost of such protection falls particularly hard on developing countrDocumentWTO TRIPS agreement and its implications for access to medicines in developing countries
Commission on Intellectual Property Rights, 2002This detailed issue briefing examines TRIPS in light of the Doha Declaration which mandates that TRIPS be interpreted in a manner that supports public health interests and promotes access to medicines.The study accepts the consensus of experts that developing countries should make use of policy options such as compulsory licensing and parallel importation to increase the supply of low-price medPages
